The Egyptian Drug Authority (EDA) held an important meeting today, chaired by Dr. Ali El Ghamrawy, Head of the Authority, to discuss the updates to the policies surrounding the registration of pharmaceutical products. The meeting also aimed to enhance cooperation with the pharmaceutical division of the Federation of Egyptian Chambers of Commerce.
Key Topics Discussed
The meeting focused on several vital topics, primarily revolving around the modernization of pharmaceutical registration processes. These updates are crucial to ensuring the continued flow of pharmaceutical products into the market and ensuring the availability of medicines for the local population. The discussions also addressed strategies to enhance drug accessibility, increase local production, and meet international regulatory and technical standards.
The representatives from the Federation of Egyptian Chambers of Commerce shared their perspectives on boosting collaboration, emphasizing the importance of adapting flexible, up-to-date systems that align with international standards. The goal is to improve transparency in the pharmaceutical market and stabilize the supply chain, ensuring that medications reach citizens with high quality and efficiency.
Strengthening Collaboration and Meeting Global Standards
The meeting reaffirmed the importance of ensuring sustainable development in the pharmaceutical sector, while also ensuring continuous adaptation to global advancements. The goal is to achieve a balance between economic growth and guaranteeing accessibility to essential medicines for all citizens.
The attendees highlighted the significance of continuing communication and coordination between all stakeholders to stay in line with global updates, ensuring alignment between pharmaceutical and regulatory policies for the betterment of Egypt’s health sector.
Attendees of the Meeting
The meeting was attended by key figures, including Dr. Ali Awad, Head of the Pharmaceutical Division at the Federation of Egyptian Chambers of Commerce, Dr. Mohamed El-Naggar, Board Member and Head of the Manufacturers Committee, Dr. Haitham Dweidar, Board Member and Head of the Industry Committee, and Eng. Yasser Waked, Board Member and Head of the Veterinary Medicine Committee.
Representatives from the Egyptian Drug Authority included Dr. Hanan Amin, Head of the Central Administration of Pharmaceutical Products, Dr. Amani Gad, Deputy Head of the Authority, Dr. Osama Hatem, Deputy Head for Policies and International Cooperation, and Dr. Hamada Gamal, Deputy Head for Registration Systems Development and Head of the Registration Department for Human Pharmaceuticals.
Ongoing Efforts for Sustainable Pharmaceutical Development
This meeting is part of the ongoing efforts by the Egyptian Drug Authority to strengthen partnerships with relevant entities and ensure a sustainable approach to pharmaceutical supply. The Authority continues to prioritize the modernization of the pharmaceutical registration system to meet the evolving needs of the healthcare sector, supporting Egypt’s drive for sustainable development in the pharmaceutical industry.
